Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000374232 | SCV000330215 | pathogenic | not provided | 2016-02-04 | criteria provided, single submitter | clinical testing | The I1357S pathogenic variant in the CACNA1A gene has not been reported previously as a pathogenic variant nor as a benign variant, to our knowledge. The I1357S variant was not observed in approximately 6000 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. The I1357S variant is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. This substitution occurs at a position that is conserved across species. In silico analysis predicts this variant is probably damaging to the protein structure/function. Missense variants in nearby residues (R1349Q, V1350L, R1359W, F1367L) have been reported in the Human Gene Mutation Database in association with CACNA1A-related disorders (Stenson et al., 2014), supporting the functional importance of this region of the protein. We interpret I1357S as a pathogenic variant. |